# Integra LifeSciences Announces Leadership Transition
Canonical URL: https://biopharmsignal.com/news/IART/integra-lifesciences-announces-leadership-transition
Ticker: IART
Company: Integra LifeSciences
Source: Integra LifeSciences
Published: 2026-05-05 10:00 EST
Original Source URL: https://investor.integralife.com
## Summary

Stuart Essig Appointed as Integra’s Next President and Chief Executive Officer Michael McBreen Appointed Chief Commercial Officer PRINCETON, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART), a leading global medical

## Article Body
Stuart Essig Appointed as Integra’s Next President and Chief Executive Officer Michael McBreen Appointed Chief Commercial Officer PRINCETON, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART), a leading global medical
## Recent Company News
- 2026-06-02 11:30 EST — [Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/IART/integra-lifesciences-to-present-at-the-2026-jefferies-global-healthcare-conference) — Source: Integra LifeSciences
- 2026-05-08 12:00 EST — [Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference](https://biopharmsignal.com/news/IART/integra-lifesciences-to-present-at-the-bofa-securities-2026-health-care-conference) — Source: Integra LifeSciences
- 2026-05-05 10:00 EST — [Integra LifeSciences Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/IART/integra-lifesciences-reports-first-quarter-2026-financial-results) — Source: Integra LifeSciences
- 2026-05-05 10:00 EST — [Integra LifeSciences Announces Leadership Transition](https://biopharmsignal.com/news/IART/integra-lifesciences-announces-leadership-transition) — Source: Integra LifeSciences
- 2026-04-20 12:32 EST — [Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026](https://biopharmsignal.com/news/IART/integra-lifesciences-to-host-first-quarter-2026-financial-results-conference-call-on-may-5-2026) — Source: Integra LifeSciences
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)